The Inspired Patent Podcast

6 Followers

Leveraging Inspiration: The Inspired Patent Podcast This podcast is for small business owners. You work so hard and help so many people. It breaks my heart when I learn of a small business owner that missed opportunities because they did not have the information that they needed. That is why I am here, to help you, the small business owner, to learn how to leverage your inspiration and succeed at making the world a better place. Listen to find out simple steps you can take to make sure you own the valuable property in your business, your inspired ideas, your innovations, and solutions. More than just protecting your intellectual property (IP), I want to help you leverage your ideas so that you can offer your solutions to as many people as possible. Each 13-week season will take you through a process in your business to improve your intellectual property protection. In each episode, I provide a small action that you can take to better protect your IP. Added together these small actions can make a huge difference for your business and the results you achieve. Join me each week for new episodes. Find new episodes on LeveraginInspiration.com and wherever you find your podcasts The first season (season 13 on IBGR.Network) covers: Intellectual Property Strategy for Startups and Small Business Show Airs - Fridays 3 pm ET beginning Apr 7, 2023

Canadian phase 2 clinical trial, recruiting patients.

0 Followers

C Difficile is a gram positive spore forming bacteria, which can cause severe gut infection. It infects and kills 500,000 and 30,000 North Americans respectively every year. Standard of care treatment is Vancomycin antibiotic, which is effective in 60 to 70% of cases. When unsuccessful, the infection can recur and likeliness of recurrence increases after every treatment failure. Its treatment is considered an unmet medical need by the FDA and as such new treatments showing positive potential are typically fast tracked. ImmuniMed Inc, a Canadian clinical stage Biopharmaceutical company is presently in phase 2 clinical trial of its oral dose antibody treatment and recruiting patients. If you are a Canadian resident, over the age of 18 and have tested positive for c Difficile, please contact us to participate in this trial. John Hare John@immunimed.com 204-955-8495

PATENT TECH

0 Followers

Welcome to PATENT TECH, where innovation meets creativity! Join us as we explore the fascinating world of technology and patents, showcasing groundbreaking inventions and the brilliant minds behind them. Whether you’re an aspiring inventor, a tech enthusiast, or just curious about the latest advancements, our channel offers insightful discussions, tutorials, and in-depth analyses. Subscribe now to stay updated on the newest trends and discover how you can turn your ideas into reality!

Power to the Patients

0 Followers

Hospitals save lives, but the hidden prices of healthcare all too often end up destroying the financial well-being of their patients, especially for the most vulnerable. Thankfully, on January 1, 2021, a new healthcare rule mandates that all hospitals must finally publish their real prices online. This breakthrough allows patients and their families an understanding of the real financial obligations of their medical decisions and even creates an opportunity for them to responsibly compare prices across hospitals. For the first time in US history, entering a hospital will not so easily lead to financial despair as a result of price gouging or unexpected medical bills. Finally, we can take care of ourselves medically while taking control of our financial health. We now have the right to see real prices before we receive care. Our Health. Our Money. Power to the Patients. Additional information at powertothepatients.org.